Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.60 |
| ▸ | CSNK1D | P48730 | 11/20 | 0.56 |
| ▸ | ACP1 | P24666 | 1/20 | 0.54 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25833329 | 1.00 | ALDH1A1 (0.67) | ALDH1A1CYP2D6DYRK1ACSNK1DACP1 | |
| SCHEMBL30451396 | 1.00 | ALDH1A1 (0.67) | ALDH1A1CYP2D6DYRK1ACSNK1DACP1 | |
| SCHEMBL30450160 | 0.92 | ALDH1A1 (0.62) | ALDH1A1CYP2D6DYRK1ACSNK1DACP1 | |
| SCHEMBL25262799 | 0.92 | ALDH1A1 (0.62) | ALDH1A1CYP2D6DYRK1ACSNK1DACP1 | |
| SCHEMBL25833569 | 0.92 | ALDH1A1 (0.62) | ALDH1A1CYP2D6DYRK1ACSNK1DACP1 | |
| SCHEMBL30450832 | 0.89 | ALDH1A1 (0.70) | ALDH1A1CYP2D6DYRK1ACSNK1D | |
| SCHEMBL25832791 | 0.89 | ALDH1A1 (0.70) | ALDH1A1CYP2D6DYRK1ACSNK1D | |
| SCHEMBL25260868 | 0.89 | ALDH1A1 (0.70) | ALDH1A1CYP2D6DYRK1ACSNK1D | |
| SCHEMBL25261844 | 0.89 | ALDH1A1 (0.59) | ALDH1A1CYP2D6DYRK1ACSNK1D | |
| SCHEMBL30450719 | 0.89 | ALDH1A1 (0.59) | ALDH1A1CYP2D6DYRK1ACSNK1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382273-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | INST NAT SANTE RECH MED (FR) | 2025-12-18 | — | — | US | claimed |
| WO-2023131649-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2023-07-13 | — | — | WO | claimed |
| US-20250382273-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | INST NAT SANTE RECH MED (FR) | 2025-12-18 | — | — | US | disclosed |
| WO-2023131649-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2023-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382273-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | BBOX1, NDUFB6, NDUFB5 | ALDH1A1 108/4885CYP2D6 91/4885DYRK1A 3574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.